DXCM currently has a PEG ratio reading of 0.76 as of Nov 11, 2026. Dividing the 31.02 PE ratio by the 40.8% earnings growth rate yields this valuation metric. When compared to the trailing four-quarter average of 0.54, DXCM's PEG ratio shows a 41% increase.
A nine years lookback shows an average PEG ratio of 2.11 for Dexcom. Compared to historical data, DXCM's 0.76 PEG ratio represents a decrease of 64%. The nine years high occurred in the Dec 2024 quarter at 12.39, reflecting maximum valuation relative to growth. The minimum was hit in the Dec 2020 quarter at 0.15, indicating optimal value relative to growth during that period.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.67 | 31.01 | 46.6% |
| 2024 | 12.39 | 53.27 | 4.3% |
| 2023 | 1.5 | 88.64 | 59.1% |
| 2022 | 2.25 | 128.68 | 57.1% |
| 2021 | N/A | 239.71 | -61.6% |
| 2020 | 0.15 | 63.31 | 421.4% |
| 2019 | 1.1 | 195.3 | 177.8% |
| 2018 | N/A | N/A | -140% |
| 2017 | N/A | N/A | 25% |
| 2016 | N/A | N/A | -11.1% |
| 2015 | N/A | N/A | -125% |
| 2014 | N/A | N/A | 27.3% |
| 2013 | N/A | N/A | 45% |
| 2012 | N/A | N/A | -17.6% |
| 2011 | N/A | N/A | 29.2% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Sep 2026 | 0.82 | 33.32 | 40.8% |
| Jun 2026 | 0.33 | 26 | 78.6% |
| Mar 2026 | 0.34 | 26.17 | 77.8% |
| Dec 2025 | 0.67 | 31.01 | 46.6% |
| Sep 2025 | 6.42 | 36.57 | 5.7% |
| Jun 2025 | N/A | 60.2 | -15.2% |
| Mar 2025 | N/A | 50.59 | -18.2% |
| Dec 2024 | 12.39 | 53.27 | 4.3% |
| Sep 2024 | 0.5 | 38.53 | 77.6% |
| Jun 2024 | 0.79 | 66.3 | 83.9% |
| Mar 2024 | 0.72 | 84.06 | 117.1% |
| Dec 2023 | 1.5 | 88.64 | 59.1% |
| Sep 2023 | 1.71 | 95.2 | 55.6% |
| Jun 2023 | 2.51 | 138.18 | 55% |
| Mar 2023 | 11.41 | 152.87 | 13.4% |
When comparing to historical values, DXCM's PEG ratio is below the 3, 5 and 10-year averages.
With a PEG of 0.76, DXCM stands above the Healthcare sector and the industry average. Compared to its Healthcare sector average of 0.62, Dexcom's PEG is 23% higher.
DXCM has a PEG ratio below that of peer stocks MDT and WST.
DXCM's Nov 11, 2026 PEG ratio comes in at 0.76.
DXCM's 3-year PEG ratio average stands at 2.45.
DXCM's 5-year PEG ratio average stands at 3.03.
In the last nine years, DXCM's peak PEG ratio of 12.39 was recorded in the Dec 2024 quarter.
Compared to the 9-year average, DXCM's PEG ratio is 64% lower.
PEG equals PE divided by EPS growth (YoY TTM). As of Nov 11, 2026, Dexcom has a P/E ratio of 31.02. Earnings grew at 40.8% over the TTM period ending Sep 2026. Applying the formula, this produces a price to earnings growth ratio of 0.76. PEG RATIO(0.76) = PE RATIO(31.02) / EPS GROWTH(40.8%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.